Leite da Silva, L. F., Figueiredo Saldanha, E., Diniz da Conceição, L., de Andrade Martins, W., Altenburg Gismondi, R., de Souza Filho, E. M., & D'Alpino Peixoto, R. (2024). Efficacy and safety of trifluridine/tipiracil plus bevacizumab across different subgroups of patients with refractory colorectal cancer: A meta-analysis. Ecancermedicalscience, 18(1706-1753), 1. https://doi.org/10.3332/ecancer.2024.1728
Chicago Style (17th ed.) CitationLeite da Silva, Luís Felipe, Erick Figueiredo Saldanha, Lucas Diniz da Conceição, Wolney de Andrade Martins, Ronaldo Altenburg Gismondi, Erito Marques de Souza Filho, and Renata D'Alpino Peixoto. "Efficacy and Safety of Trifluridine/tipiracil Plus Bevacizumab Across Different Subgroups of Patients with Refractory Colorectal Cancer: A Meta-analysis." Ecancermedicalscience 18, no. 1706-1753 (2024): 1. https://doi.org/10.3332/ecancer.2024.1728.
MLA (9th ed.) CitationLeite da Silva, Luís Felipe, et al. "Efficacy and Safety of Trifluridine/tipiracil Plus Bevacizumab Across Different Subgroups of Patients with Refractory Colorectal Cancer: A Meta-analysis." Ecancermedicalscience, vol. 18, no. 1706-1753, 2024, p. 1, https://doi.org/10.3332/ecancer.2024.1728.